Analystreport

Epizyme, Inc. (NASDAQ: EPZM) had its price target lowered by analysts at Citigroup Inc. from $35.00 to $27.00.

Epizyme, Inc.  (EPZM) 
Last epizyme, inc. earnings: 2/24 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: epizyme.com